BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 36585906)

  • 41. Long non-coding RNA ZFAS1 promotes proliferation and metastasis of clear cell renal cell carcinoma via targeting miR-10a/SKA1 pathway.
    Dong D; Mu Z; Wei N; Sun M; Wang W; Xin N; Shao Y; Zhao C
    Biomed Pharmacother; 2019 Mar; 111():917-925. PubMed ID: 30841471
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Guanine nucleotide-binding protein 2, GNBP2, accelerates the progression of clear cell renal cell carcinoma via regulation of STAT3 signaling transduction pathway.
    Cao Q; Ma J; Li W; Hong P; Shen T; Tong M
    Genes Genomics; 2023 Jan; 45(1):1-11. PubMed ID: 36346541
    [TBL] [Abstract][Full Text] [Related]  

  • 43. HAO2 inhibits malignancy of clear cell renal cell carcinoma by promoting lipid catabolic process.
    Xiao W; Wang X; Wang T; Chen B; Xing J
    J Cell Physiol; 2019 Dec; 234(12):23005-23016. PubMed ID: 31127626
    [TBL] [Abstract][Full Text] [Related]  

  • 44. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Role of Serine Peptidase Inhibitor Kazal Type 13 (SPINK13) as a Clinicopathological and Prognostic Biomarker in Patients with Clear Cell Renal Cell Carcinoma.
    Xu WH; Shi SN; Wang J; Xu Y; Tian X; Wan FN; Cao DL; Qu YY; Zhang HL; Ye DW
    Med Sci Monit; 2019 Dec; 25():9458-9470. PubMed ID: 31825950
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. LncRNA TP73-AS1 Promotes Cell Proliferation and Inhibits Cell Apoptosis in Clear Cell Renal Cell Carcinoma Through Repressing KISS1 Expression and Inactivation of PI3K/Akt/mTOR Signaling Pathway.
    Liu G; Zhao X; Zhou J; Cheng X; Ye Z; Ji Z
    Cell Physiol Biochem; 2018; 48(1):371-384. PubMed ID: 30016766
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Low expression of phosphatase and tensin homolog in clear‑cell renal cell carcinoma contributes to chemoresistance through activating the Akt/HDM2 signaling pathway.
    Chen J; Zhu H; Zhang Y; Cui MH; Han LY; Jia ZH; Wang L; Teng H; Miao LN
    Mol Med Rep; 2015 Aug; 12(2):2622-8. PubMed ID: 25954860
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hypoxia-induced overexpression of stanniocalcin-1 is associated with the metastasis of early stage clear cell renal cell carcinoma.
    Ma X; Gu L; Li H; Gao Y; Li X; Shen D; Gong H; Li S; Niu S; Zhang Y; Fan Y; Huang Q; Lyu X; Zhang X
    J Transl Med; 2015 Feb; 13():56. PubMed ID: 25740019
    [TBL] [Abstract][Full Text] [Related]  

  • 50. HAPLN3 inhibits apoptosis and promotes EMT of clear cell renal cell carcinoma via ERK and Bcl-2 signal pathways.
    Ding Y; Xiong S; Chen X; Pan Q; Fan J; Guo J
    J Cancer Res Clin Oncol; 2023 Jan; 149(1):79-90. PubMed ID: 36374334
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Elevated Expression of ADAP2 is Associated With Aggressive Behavior of Human Clear-Cell Renal Cell Carcinoma and Poor Patient Survival.
    Qiang Y; Wang X; Ding J; Wang Z; Li B; Ji H; Zhang X; Yang Y; Liu K; Zhang L; Ma S; Zhao D; Lu G
    Clin Genitourin Cancer; 2023 Apr; 21(2):e78-e91. PubMed ID: 36127253
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Knockdown of the nucleosome binding protein 1 inhibits the growth and invasion of clear cell renal cell carcinoma cells in vitro and in vivo.
    Ji SQ; Yao L; Zhang XY; Li XS; Zhou LQ
    J Exp Clin Cancer Res; 2012 Mar; 31(1):22. PubMed ID: 22420896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. MiR-6838-5p facilitates the proliferation and invasion of renal cell carcinoma cells through inhibiting the DMTF1/ARF-p53 axis.
    Zhai X; Wu Y; Zhang D; Li H; Chong T; Zhao J
    J Bioenerg Biomembr; 2021 Apr; 53(2):191-202. PubMed ID: 33686550
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mammalian SIRT4 is a tumor suppressor of clear cell renal cell carcinoma by inhibiting cancer proliferation, migration and invasion.
    Wang C; Piao C; Liu J; Zhang Z; Zhu Y; Kong C
    Cancer Biomark; 2020; 29(4):453-462. PubMed ID: 32675395
    [TBL] [Abstract][Full Text] [Related]  

  • 55. p53 is functionally inhibited in clear cell renal cell carcinoma (ccRCC): a mechanistic and correlative investigation into genetic and molecular characteristics.
    Diesing K; Ribback S; Winter S; Gellert M; Oster AM; Stühler V; Gläser E; Adler F; Hartwig C; Scharpf M; Bedke J; Burchardt M; Schwab M; Lillig CH; Kroeger N
    J Cancer Res Clin Oncol; 2021 Dec; 147(12):3565-3576. PubMed ID: 34499221
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MiR-30a suppresses clear cell renal cell carcinoma proliferation and metastasis by targeting LRP6.
    Ren Y; Zhang L; Zhang W; Gao Y
    Hum Cell; 2021 Mar; 34(2):598-606. PubMed ID: 33400244
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Silencing of circular RNA PUM1 inhibits clear cell renal cell carcinoma progression through the miR-340-5p/FABP7 axis.
    Zeng F; Luo L; Song M; Li D
    J Recept Signal Transduct Res; 2022 Apr; 42(2):141-150. PubMed ID: 33472512
    [TBL] [Abstract][Full Text] [Related]  

  • 58. MIIP inhibits clear cell renal cell carcinoma proliferation and angiogenesis
    Yan F; Wang Q; Xia M; Ru Y; Hu W; Yan G; Xiong X; Zhang M; Wang J; Li Q; Zhang B; Wang H; Lin W; Wu G; Li X
    Cancer Biol Med; 2021 Dec; 19(6):818-35. PubMed ID: 34931765
    [TBL] [Abstract][Full Text] [Related]  

  • 59. TUBB3 Is Associated with High-Grade Histology, Poor Prognosis, p53 Expression, and Cancer Stem Cell Markers in Clear Cell Renal Cell Carcinoma.
    Sekino Y; Han X; Babasaki T; Miyamoto S; Kitano H; Kobayashi G; Goto K; Inoue S; Hayashi T; Teishima J; Sakamoto N; Sentani K; Oue N; Yasui W; Matsubara A
    Oncology; 2020; 98(10):689-698. PubMed ID: 32585672
    [TBL] [Abstract][Full Text] [Related]  

  • 60. PML restrains p53 activity and cellular senescence in clear cell renal cell carcinoma.
    Simoni M; Menegazzi C; Fracassi C; Biffi CC; Genova F; Tenace NP; Lucianò R; Raimondi A; Tacchetti C; Brugarolas J; Mazza D; Bernardi R
    EMBO Mol Med; 2024 Jun; 16(6):1324-1351. PubMed ID: 38730056
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.